200 Middlesex Essex Turnpike - Suite 210 Iselin NJ 08830 USA [t] 001 732 404 1117
SyntheMed is a biomaterials company engaged in the development and commercialisation of anti-adhesion products and other surgical implants based on proprietary bioresorbable polymer technology.
The US Food and Drug Administration (FDA) has approved the Pre-market Approval (PMA) application for SyntheMed’s REPEL-CV Adhesion Barrier for use in paediatric cardiac surgery patients.
SyntheMed has received FDA 510(k) clearance to market SinusShield, a bioresorbable membrane intended to prevent post-operative adhesions in nasal and sinus surgical procedures.
